150 related articles for article (PubMed ID: 27600621)
1. Proposal of the Coagulation Score as a Predictor for Short-Term and Long-Term Outcomes of Patients with Resectable Gastric Cancer.
Kanda M; Tanaka C; Kobayashi D; Mizuno A; Tanaka Y; Takami H; Iwata N; Hayashi M; Niwa Y; Yamada S; Fujii T; Sugimoto H; Murotani K; Fujiwara M; Kodera Y
Ann Surg Oncol; 2017 Feb; 24(2):502-509. PubMed ID: 27600621
[TBL] [Abstract][Full Text] [Related]
2. Postoperative D-dimer elevation affects tumor recurrence and the long-term survival in gastric cancer patients who undergo gastrectomy.
Hara K; Aoyama T; Hayashi T; Nakazono M; Nagasawa S; Shimoda Y; Kumazu Y; Numata M; Yamada T; Tamagawa H; Shiozawa M; Morinaga S; Yukawa N; Rino Y; Masuda M; Ogata T; Oshima T
Int J Clin Oncol; 2020 Apr; 25(4):584-594. PubMed ID: 31865480
[TBL] [Abstract][Full Text] [Related]
3. A Novel Preoperative Skeletal Muscle Measure as a Predictor of Postoperative Complications, Long-Term Survival and Tumor Recurrence for Patients with Gastric Cancer After Radical Gastrectomy.
Lu J; Zheng ZF; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Huang CM
Ann Surg Oncol; 2018 Feb; 25(2):439-448. PubMed ID: 29181681
[TBL] [Abstract][Full Text] [Related]
4. Excellent Long-Term Prognosis and Favorable Postoperative Nutritional Status After Laparoscopic Pylorus-Preserving Gastrectomy.
Tsujiura M; Hiki N; Ohashi M; Nunobe S; Kumagai K; Ida S; Hayami M; Sano T; Yamaguchi T
Ann Surg Oncol; 2017 Aug; 24(8):2233-2240. PubMed ID: 28280944
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Plasma Fibrinogen and Serum Albumin Score Is an Independent Prognostic Factor for Resectable Stage II-III Gastric Cancer.
Wu M; Pan Y; Jia Z; Wang Y; Yang N; Mu J; Zhou T; Guo Y; Jiang J; Cao X
Dis Markers; 2019; 2019():9060845. PubMed ID: 31781312
[TBL] [Abstract][Full Text] [Related]
7. Adverse Effects of Intraoperative Blood Loss on Long-Term Outcomes after Curative Gastrectomy of Patients with Stage II/III Gastric Cancer.
Mizuno A; Kanda M; Kobayashi D; Tanaka C; Iwata N; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Dig Surg; 2016; 33(2):121-8. PubMed ID: 26745751
[TBL] [Abstract][Full Text] [Related]
8. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of serum D-dimer, fibrinogen, and CA19-9 for postoperative monitoring and survival prediction in resectable pancreatic carcinoma.
Cao J; Fu Z; Gao L; Wang X; Cheng S; Wang X; Ren H
World J Surg Oncol; 2017 Feb; 15(1):48. PubMed ID: 28219450
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative blood loss does not independently affect the survival outcome of gastric cancer patients who underwent curative resection.
Zhao B; Huang X; Lu H; Zhang J; Luo R; Xu H; Huang B
Clin Transl Oncol; 2019 Sep; 21(9):1197-1206. PubMed ID: 30689183
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of D-dimer levels in patients with gastric cancer undergoing gastrectomy.
Kim EY; Song KY
Surg Oncol; 2021 Jun; 37():101570. PubMed ID: 33839443
[TBL] [Abstract][Full Text] [Related]
12. The Controlling Nutritional Status Score Serves as a Predictor of Short- and Long-Term Outcomes for Patients with Stage 2 or 3 Gastric Cancer: Analysis of a Multi-institutional Data Set.
Ryo S; Kanda M; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Tanaka C; Kobayashi D; Fujiwara M; Murotani K; Kodera Y
Ann Surg Oncol; 2019 Feb; 26(2):456-464. PubMed ID: 30565044
[TBL] [Abstract][Full Text] [Related]
13. Predicting recurrence after curative resection for gastric cancer: External validation of the Italian Research Group for Gastric Cancer (GIRCG) prognostic scoring system.
Barchi LC; Yagi OK; Jacob CE; Mucerino DR; Ribeiro U; Marrelli D; Roviello F; Cecconello I; Zilberstein B
Eur J Surg Oncol; 2016 Jan; 42(1):123-31. PubMed ID: 26365755
[TBL] [Abstract][Full Text] [Related]
14. Elevated high-sensitivity C-reactive protein, a marker of advanced stage gastric cancer and postgastrectomy disease recurrence.
Woo Y; Hyung WJ; Obama K; Kim HI; Pak KH; Son T; Noh SH
J Surg Oncol; 2012 Mar; 105(4):405-9. PubMed ID: 22025360
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomy.
Bilici A; Salman T; Oven Ustaalioglu BB; Unek T; Seker M; Aliustaoglu M; Gezen C; Unek T; Yavuzer D; Unlu M; Gumus M; Yilmaz U
J Surg Res; 2013 Mar; 180(1):e1-9. PubMed ID: 22520575
[TBL] [Abstract][Full Text] [Related]
16. Effect of hospital volume on long-term outcomes of laparoscopic gastrectomy for clinical stage I gastric cancer.
Ichikawa D; Komatsu S; Kubota T; Okamoto K; Deguchi K; Tamai H; Obayashi T; Kitagawa K; Soga K; Inoue K; Yamaoka N; Imanishi T; Hagiwara A; Otsuji E
Anticancer Res; 2013 Nov; 33(11):5165-70. PubMed ID: 24222165
[TBL] [Abstract][Full Text] [Related]
17. Node-extranodal soft tissue stage based on extranodal metastasis is associated with poor prognosis of patients with gastric cancer.
Jiang N; Deng JY; Ding XW; Ke B; Liu N; Liang H
J Surg Res; 2014 Nov; 192(1):90-7. PubMed ID: 24953988
[TBL] [Abstract][Full Text] [Related]
18. Early detection of nonperitoneal recurrence may contribute to survival benefit after curative gastrectomy for gastric cancer.
Fujiya K; Tokunaga M; Makuuchi R; Nishiwaki N; Omori H; Takagi W; Hirata F; Hikage M; Tanizawa Y; Bando E; Kawamura T; Terashima M
Gastric Cancer; 2017 Mar; 20(Suppl 1):141-149. PubMed ID: 27778124
[TBL] [Abstract][Full Text] [Related]
19. Adverse prognostic impact of perioperative allogeneic transfusion on patients with stage II/III gastric cancer.
Kanda M; Kobayashi D; Tanaka C; Iwata N; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Nomoto S; Murotani K; Fujiwara M; Kodera Y
Gastric Cancer; 2016 Jan; 19(1):255-63. PubMed ID: 25563579
[TBL] [Abstract][Full Text] [Related]
20. FAM46C Serves as a Predictor of Hepatic Recurrence in Patients with Resectable Gastric Cancer.
Tanaka H; Kanda M; Shimizu D; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Niwa Y; Kodera Y
Ann Surg Oncol; 2017 Oct; 24(11):3438-3445. PubMed ID: 27770343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
